Cargando…
Biomarker Application for Precision Medicine in Stroke
Stroke remains one of the leading causes of long-term disability and mortality despite recent advances in acute thrombolytic therapies. In fact, the global lifetime risk of stroke in adults over the age of 25 is approximately 25%, with 24.9 million cases of ischemic stroke and 18.7 million cases of...
Autores principales: | Simpkins, Alexis N., Janowski, Miroslaw, Oz, Helieh S., Roberts, Jill, Bix, Gregory, Doré, Sylvain, Stowe, Ann M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299765/ https://www.ncbi.nlm.nih.gov/pubmed/31848851 http://dx.doi.org/10.1007/s12975-019-00762-3 |
Ejemplares similares
-
Application of Prodrugs to Inflammatory Diseases of the Gut
por: Oz, Helieh S., et al.
Publicado: (2008) -
Mice deficient in endothelial α5 integrin are profoundly resistant to experimental ischemic stroke
por: Roberts, Jill, et al.
Publicado: (2015) -
Maternal and congenital toxoplasmosis, currently available and novel therapies in horizon
por: Oz, Helieh S.
Publicado: (2014) -
Toxoplasmosis complications and novel therapeutic synergism combination of diclazuril plus atovaquone
por: Oz, Helieh S.
Publicado: (2014) -
Toxoplasmosis, Pancreatitis, Obesity and Drug Discovery
por: Oz, Helieh S.
Publicado: (2014)